Streptozotocin-treated type 1 diabetes model mice showed induced expression of the CAR target gene, Cyp2b10, following an increase in blood glucose levels, and insulin treatment clearly attenuated these inductions [9]. The gene discussed is INS; the disease is type 1 diabetes mellitus.